<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 29853458
You can only predict things after they have happened. —Eugene Ionesco Is that really true? What is clear is that better surrogate end points are needed for follicular lymphoma (FL) clinical trials so we can predict outcomes before they actually occur; to this end, in this issue of Blood, Cottereau et al provide valuable direction.1 FL is the most common of the indolent non-Hodgkin lymphomas.
Humans, Prognosis, Lymphoma, Follicular
Humans, Prognosis, Lymphoma, Follicular
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |